Fifthly, the involvement of SLC14A1 in hypoxia-driven renal cell carcinoma progression via mitochondrial-dependent pathways implies that oxygen-targeted therapeutic approaches could potentially improve treatment outcomes for this malignancy. The gene discussed is SLC14A1; the disease is hereditary clear cell renal cell carcinoma.